Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - EPIRUS Biopharmaceuticals, Inc. | a15-22411_3ex99d1.htm |
| EX-99.2 - EX-99.2 - EPIRUS Biopharmaceuticals, Inc. | a15-22411_3ex99d2.htm |
| 8-K/A - 8-K/A - EPIRUS Biopharmaceuticals, Inc. | a15-22411_38ka.htm |
Exhibit 23.1
Consent of Independent Auditors
We consent to the incorporation by reference in the Registration Statement (Form S-3 No. 333-205420) and related Prospectus of EPIRUS Biopharmaceuticals, Inc. for the registration of up to $ 125,000,000 of debt securities, preferred stock, common stock, warrants and/or units, of our report dated November 16, 2015, with respect to the consolidated financial statements of Bioceros Holding B.V. included in this Current Report (Form 8-K ) of EPIRUS Biopharmaceuticals, Inc. dated November 16, 2015.
/s/ Ernst & Young Accountants LLP
Amsterdam, the Netherlands
November 16, 2015